10x Genomics, Inc. - Laporan Laba Rugi (TTM)

10x Genomics, Inc.
US ˙ NasdaqGS ˙ US88025U1097

Laporan Laba Rugi (TTM)

Laporan Laba Rugi 10x Genomics, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 262 299 333 406 459 490 499 498 504 516 536 568 591 619 625 632 630 611 625 644
Change (%) 14.10 11.35 21.92 13.18 6.82 1.77 -0.25 1.16 2.52 3.83 6.01 3.97 4.70 1.09 1.00 -0.32 -3.01 2.27 3.17
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 50 58 65 55 80 74 83 105 96 120 131 150 178 209 221 223 210 196 198 196
Change (%) 16.81 10.86 -14.71 44.87 -7.49 11.36 27.62 -8.40 24.50 8.67 14.94 18.49 17.82 5.68 0.76 -5.76 -6.72 0.84 -0.74
% of Revenue 19.11 19.56 19.48 13.63 17.44 15.11 16.53 21.15 19.15 23.25 24.34 26.39 30.08 33.85 35.38 35.30 33.37 32.09 31.64 30.44
Gross Operating Profit 212 240 268 350 379 416 417 393 407 396 406 418 413 409 404 409 420 415 427 448
Change (%) 13.46 11.47 30.78 8.18 9.84 0.06 -5.77 3.72 -2.68 2.36 3.13 -1.23 -0.95 -1.26 1.14 2.66 -1.15 2.95 4.98
% of Revenue 80.89 80.44 80.52 86.37 82.56 84.89 83.47 78.85 80.85 76.75 75.66 73.61 69.92 66.15 64.62 64.70 66.63 67.91 68.36 69.56
SG&A 185 202 209 233 244 258 267 278 289 296 312 322 331 343 345 339 331 343 348 338
Change (%) 9.30 3.22 11.63 4.52 5.71 3.79 3.98 4.07 2.25 5.61 3.00 2.81 3.79 0.41 -1.65 -2.37 3.69 1.47 -2.96
% of Revenue 70.67 67.70 62.76 57.46 53.06 52.51 53.56 55.82 57.43 57.28 58.26 56.61 55.98 55.49 55.12 53.67 52.57 56.20 55.76 52.44
R&D 112 123 139 165 190 212 234 251 264 264 267 268 267 266 267 258 260 264 260 255
Change (%) 10.59 12.88 18.57 14.80 11.70 10.48 7.39 5.06 0.12 1.14 0.29 -0.29 -0.58 0.32 -3.20 0.84 1.46 -1.40 -2.15
% of Revenue 42.59 41.28 41.85 40.70 41.29 43.17 46.87 50.45 52.40 51.17 49.85 47.16 45.23 42.95 42.62 40.84 41.32 43.22 41.67 39.52
OpEx 347 384 413 454 513 543 584 634 650 680 710 740 776 818 833 820 801 803 806 789
Change (%) 10.80 7.49 9.84 13.18 5.86 7.43 8.69 2.39 4.69 4.42 4.18 4.86 5.50 1.73 -1.51 -2.28 0.24 0.37 -2.16
% of Revenue 132.38 128.55 124.09 111.79 111.79 110.79 116.95 127.43 128.98 131.71 132.45 130.16 131.28 132.28 133.12 129.81 127.25 131.51 129.07 122.41
Operating Income -85 -85 -80 -48 -54 -53 -85 -137 -146 -164 -174 -171 -185 -200 -207 -188 -172 -192 -182 -144
Change (%) 0.61 -6.04 -40.32 13.15 -2.27 59.93 61.38 6.90 12.17 6.26 -1.47 7.82 8.06 3.71 -9.09 -8.88 12.15 -5.65 -20.48
% of Revenue -32.38 -28.55 -24.09 -11.79 -11.79 -10.79 -16.95 -27.43 -28.98 -31.71 -32.45 -30.16 -31.28 -32.28 -33.12 -29.81 -27.25 -31.51 -29.07 -22.41
Interest Expense -2 -2 -1 -1 -1 -1 -1 -1 -1 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0
Change (%) -28.64 -26.22 -7.82 -15.56 -10.35 -10.74 -12.94 -15.60 -16.20 -22.90 -28.34 -42.97 -78.00 -54.55 -26.67 9.09 -66.67 -25.00 66.67
% of Revenue -0.90 -0.56 -0.37 -0.28 -0.21 -0.18 -0.15 -0.14 -0.11 -0.09 -0.07 -0.05 -0.03 -0.01 -0.00 -0.00 -0.00 -0.00 -0.00 -0.00
Net Income -134 -543 -533 -504 -455 -58 -89 -142 -167 -166 -174 -172 -223 -255 -264 -240 -183 -183 -157 -85
Change (%) 304.14 -1.77 -5.46 -9.66 -87.21 53.01 59.95 17.36 -0.74 5.02 -1.17 29.64 14.21 3.61 -9.28 -23.87 0.04 -14.01 -46.13
% of Revenue -51.27 -181.61 -160.22 -124.24 -99.17 -11.87 -17.85 -28.62 -33.20 -32.15 -32.51 -30.31 -37.80 -41.23 -42.26 -37.96 -28.99 -29.90 -25.14 -13.13

Source: Capital IQ

Other Listings
MX:TXG
GB:0A88
DE:1KJ € 11.30
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista